Categories: Healthcare-associated infections
January 5th, 2011 3:32 pm ET -
Denise J. Jamieson, M.D.
Author — Denise J. Jamieson, M.D.
CDC’s Division of Reproductive Health
As an obstetrician-gynecologist who practices at Grady, a large urban teaching hospital in Atlanta, I often have the opportunity to witness how guidance developed at CDC is translated into clinical practice. For example, in my role as a CDC medical officer, I participated in the CDC workgroup that helped develop the 2010 revised guidelines for the prevention of perinatal Group B Streptococcal (GBS) disease. Following the release of the new guidelines, I was able to see how the recommendations were interpreted and used in my role as a practicing obstetrician-gynecologist at Grady.
Shorty after the release of the revised GBS guidelines, Dr. Catherine Hudson, one of the Emory residents, presented the new recommendations on morning rounds while I was the attending physician on labor and delivery. To me, one of the many delightful (and humbling!) things about being at a teaching hospital is how much you can learn from the residents! Dr. Hudson was able to distill the essential points of the 32-page document concisely and accurately while integrating her own clinical perspective.
4 Comments -
Categories: Healthcare-associated infections, Long Term Care (LTC), Outpatient Care
December 15th, 2010 11:45 am ET -
CDC's Safe Healthcare Blog
Patsy Tassler Kelso, Ph.D.
Guest author – Patsy Tassler Kelso, Ph.D.
Vermont Department of Health – Infectious Disease
Vermont is taking on an exciting new project to prove that preventing healthcare-associated infections is a “winnable battle.”
We recognize that infections occur in all healthcare settings, and that multi-drug resistant organisms (MDRO) can travel with patients. That’s why the Vermont Department of Health, in partnership with CDC, Vermont Program for Quality in Health Care, and healthcare facilities statewide have formed the Vermont MDRO Prevention Collaborative. Our collaborative is bringing hospitals and nursing homes together in this effort – getting front-line staff to share ideas, bringing acute care infection prevention experience into long-term care settings.
Why nursing homes? Vermont has only 14 hospitals, and half are small critical access facilities. There are almost 3 times as many long-term care facilities providing skilled nursing care; they are a key partner. We’re proud to say that every Vermont hospital, along with one hospital in New Hampshire, and more than three-quarters of the nursing homes with skilled nursing facilities have joined the collaborative.
5 Comments -
Categories: Antibiotic use, Healthcare-associated infections, Long Term Care (LTC)
December 9th, 2010 3:21 pm ET -
CDC's Safe Healthcare Blog
Nimalie Stone, MD
Author — Nimalie Stone, M.D.
CDC’s Division of Healthcare Quality Promotion
As a healthcare professional, I have had the opportunity to work in nursing homes for many years both as a physician, as well as a consultant for infection control programs. When we say “nursing home,” many of us imagine communal living environments where frail elders receive basic support and assistance with activities like bathing, dressing, and preparing meals. However, much of this type of care has shifted to assisted living facilities. At the same time, nursing homes have undergone an extreme make-over; I have witnessed this transformation firsthand. The resident population and the care they receive are rapidly changing. And we must keep up.
Each year, more than 3 million people receive care in nursing homes – a 10% increase over the past 10 years. As this population has grown, we have seen a decline in another area – a 16% drop in the number of nursing home beds. How can more people be receiving care when beds are decreasing?
One explanation is that a growing proportion of people come to nursing homes directly from hospitals not to live, but for temporary care to gain strength and complete therapy before returning back to the community. For this “short-stay” population, nursing homes are not a destination, but a bridge along the journey from the hospital to home.
14 Comments -
Categories: Antibiotic use, Antimicrobial Resistance
November 19th, 2010 12:11 pm ET -
Ramanan Laxminarayan, Ph.D.
Guest author - Ramanan Laxminarayan, Ph.D.
Director of the Center for Disease Dynamics, Economics & Policy and an associate research scholar and lecturer at Princeton University.
Through Get Smart, CDC has raised awareness of antibiotic resistance as a serious public health concern that requires action. But where is resistance changing and at what rates? Is any region at particular risk? Are there patterns to its emergence that vary among different combinations of bacteria and antibiotics?
It is with these questions in mind that Extending the Cure has launched ResistanceMap—a new tool for visualizing resistance over time. Our beta version of ResistanceMap takes four common antibiotics (imipenem, methicillin, trimethoprim sulfa, and ciprofloxacin) and charts the resistance of common bacteria (Acinetobacter baumannii, Staphylococcus aureus, and Escherichia coli) over the first decade of the 21st century. Each progression shows how resistance has changed from year to year, by U.S. census divisions.
10 Comments -
Categories: Antibiotic use, Antimicrobial Resistance, NHSN
November 17th, 2010 4:39 pm ET -
Elizabeth S. Dodds Ashley, PharmD, MHS, BCPS
Guest author - Elizabeth Dodds Ashley, PharmD, MHS, FCCP, BCPS
Associate Director of Clinical Pharmacy Services and Antimicrobial Stewardship Pharmacist – University of Rochester Medical Center, Rochester, NY
Although this question sounds simple on the surface, answering it is one of the biggest challenges to stewardship programs both old and new. Unlike our infection prevention colleagues, antimicrobial stewards lack a uniform tool to measure and report antimicrobial utilization in a consistent way that facilitates benchmarking with similar institutions. Knowing how utilization compares with other centers is an invaluable tool in a field such as antimicrobial stewardship where utilization is driven by trends in resistance and changed by emerging infections making goal utilization an ever moving target.
4 Comments -